NANOBIOTIX NBTX
SPONSORED ADS · ADR · CUSIP 63009J107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.53.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 5 |
| Q2 2023 | 6 |
| Q3 2023 | 11 |
| Q4 2023 | 13 |
| Q1 2024 | 13 |
| Q2 2024 | 13 |
| Q3 2024 | 11 |
| Q4 2024 | 19 |
| Q1 2025 | 13 |
| Q2 2025 | 11 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 7 | 3 |
| Q4 2023 | 6 | 6 |
| Q1 2024 | 5 | 3 |
| Q2 2024 | 4 | 4 |
| Q3 2024 | 2 | 4 |
| Q4 2024 | 11 | 5 |
| Q1 2025 | 2 | 11 |
| Q2 2025 | 5 | 5 |
Biggest buyers
| UBS Group AG | Added | +1.4k |
| EverSource Wealth Advisors, LLC | New | +517 |
| ROYAL BANK OF CANADA | Added | +114 |
| BNP PARIBAS FINANCIAL MARKETS | Added | +100 |
| NATIONAL BANK OF CANADA /FI/ | New | +13 |
Biggest sellers
| PERCEPTIVE ADVISORS LLC | Sold out | -105.1k |
| JANE STREET GROUP, LLC | Sold out | -11.4k |
| MORGAN STANLEY | Reduced | -800 |
| BANK OF AMERICA CORP /DE/ | Sold out | -706 |
| CITIGROUP INC | Sold out | -241 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Invus Global Management, LLC 13G · passive investor +0.5 pts · filed 2026-08-13 | 9.4% |
| Qatar Investment Authority 13G · passive investor filed 2026-07-29 | 7.0% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| JOHNSON & JOHNSON 7.62% of their portfolio | 5.6m $25.5m | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 10.2k $48.2k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 5.3k $25.1k | Reduced -800 |
| UBS Group AG 0.00% of their portfolio | 4.4k $20.9k | Added +1.4k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 761 $3.6k | Added +100 |
| EverSource Wealth Advisors, LLC 0.00% of their portfolio | 517 $2.4k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 250 $2.0k | Added +114 |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 33 $156 | Unchanged |
| NATIONAL BANK OF CANADA /FI/ 0.00% of their portfolio | 13 $61 | New |
| BARCLAYS PLC 0.00% of their portfolio | 4 $19 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |